CN105901445A - 复方富勒烯保健饮用水及其制备方法 - Google Patents
复方富勒烯保健饮用水及其制备方法 Download PDFInfo
- Publication number
- CN105901445A CN105901445A CN201610227686.7A CN201610227686A CN105901445A CN 105901445 A CN105901445 A CN 105901445A CN 201610227686 A CN201610227686 A CN 201610227686A CN 105901445 A CN105901445 A CN 105901445A
- Authority
- CN
- China
- Prior art keywords
- lmai
- lto
- singer
- tricholoma matsutake
- fullerene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 229910003472 fullerene Inorganic materials 0.000 title claims abstract description 31
- 150000001875 compounds Chemical class 0.000 title claims abstract description 14
- 239000003651 drinking water Substances 0.000 title claims abstract description 14
- 235000020188 drinking water Nutrition 0.000 title claims abstract description 14
- 230000036541 health Effects 0.000 title abstract description 8
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 55
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 11
- 206010028980 Neoplasm Diseases 0.000 abstract description 9
- 150000003254 radicals Chemical class 0.000 abstract description 8
- 201000011510 cancer Diseases 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract 2
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 11
- 210000004881 tumor cell Anatomy 0.000 description 9
- 238000002791 soaking Methods 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- VSMOENVRRABVKN-UHFFFAOYSA-N oct-1-en-3-ol Chemical compound CCCCCC(O)C=C VSMOENVRRABVKN-UHFFFAOYSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000007321 biological mechanism Effects 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- -1 lipids compound Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Plant Substances (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种复方富勒烯保健饮用水，包括下列组份：富勒烯5ppm至200ppm；松茸提取物5ppm至500ppm。还公开了上述保健饮用水的制备方法，本发明将富勒烯与松茸提取物进行混合，强力抗氧化，清除自由基，达到防癌抗癌的效果，而且步骤简单、环保；同时，经过白酒浸泡的松茸取出洗净后还可以用来食用，避免资源浪费。
Description
技术领域
本发明涉及保健药剂领域，特别涉及一种复方富勒烯保健饮用水及其制备方法。
背景技术
自由基是机体氧化反应中产生的产物，具有强氧化性，可损害机体的组织和细胞，造成细胞突变，突变的细胞发生不正常的增生现象，增生的细胞就称为癌细胞。癌细胞没有任何的功能，却会在人体内四处游走，掠夺体内的养分，影响正常细胞的生长，并会无限制地复制生长，转移到身体的其他位置，因此，每个人都有很大的几率得癌症，预防癌症最有效的方法就是清除自由基。
富勒烯C60是一种天然化合物，每个球形分子包含60个小于一纳米的碳原子。水合富勒烯C60HyFn中的C60是一种被高度有序的水膜所包围的大分子结构。它的自然结构与人体健康状态下水结构高度吻合。人体组成的成分中，水的含量大约占到体重的75-80％。因此恢复人体健康应当首先维持水到稳定状态。
富勒烯因含有大量电子，可以及时给机体细胞补充电子，清除自由基，达到抗氧化的目的，从根本防止细胞畸变。其作用的生物学机制跟许多传统的抗氧化剂的生物活性机制有着本质的区别。它的抗氧化性是人们所熟悉的如维生素A、C或E，以及天然类胡萝卜素、类黄酮等抗氧化剂的成百上千倍。多年研究结果表明，含有小剂量水合富勒烯的化合物有着广泛而普遍的生物效应。其范围如下：
1、调节脂质过氧化过程，并有助于细胞膜脂质化合物的归一化，提高其对不利因素的抗性；
2、恢复细胞内的能量氧化过程；
3、激活细胞分化和组织再生的过程；
4、激活人体自身的抗氧化防御系统；
5、具有积极的免疫调节性能和抗干扰免疫系统；
6、具有持久的抗组胺和抗炎作用；
7、具有抗组胺和降血脂的性能；
8、能够有效保护肝脏、心脏、神经免受辐射；
9、对抗胃渍疡、抗烧伤和伤口愈合性质有着显著的疗效，配合温和的抗菌药物治疗有着更好的疗效；
10、具有适应原和抗压特性；
11、抑制年龄老化现象(如老化，更年期，身体脱水等)
松茸中含有珍贵的活性物质——松茸醇，松茸体内含有一种其他任何植物都没有的特殊双链生物活性物质——松茸醇(RNA)，它具有超强抗基因突变能力和强抗癌作用，能自动识别肿瘤细胞所分泌的毒素，靶向性地与肿瘤细胞靠近、结合，通过溶解肿瘤细胞膜和破坏脂质双层进入细胞内，封闭肿瘤细胞的转体蛋白受体，阻断肿瘤细胞的蛋白质合成，使肿瘤细胞不能分裂繁殖以致死亡；破坏肿瘤细胞遗传复制的DNA基因，从而达到抗基因突变，抑制肿瘤和控制肿瘤复发、转移的目的。
松茸具有很好的抗肿瘤活性，所含多糖的抗肿瘤活性远远高于灵芝，在15种具有抗肿瘤活性的食用菌中居于首位。其子实体热水提取物(多糖类)对小白鼠肉瘤S-180的抑制率高达91.8％，对艾氏腹水癌的抑制率为70％。另外有研究表明，松茸糖蛋白MTSO对人乳腺癌(MCF-7)细胞系也有抑制作用，作用的同时它对正常细胞的毒性很低。同时松茸多糖还能够诱导K562细胞凋亡，抑制白细胞增殖；研究还表明肝癌患者在肝癌切除后服用松茸.能够明显提高存活率，并且可使GOT，r-GTP，胆红素值明显降低。
研究表明，松茸的抗肿瘤作用表现为两个方面：一方面是直接杀死肿瘤细胞。实验发现松茸中含有的某些蛋白能直接杀死皮肤癌、子宫癌的癌细胞。另一方面是诱导肿瘤细胞凋亡，实验发现松茸中某些活性糖蛋白能通过抑制癌细胞在周期中S到G2M期的转化阶段抑制HeLa细胞增殖，诱导细胞发生调亡。
发明内容
发明目的：本发明的目的是为了弥补现有研究技术的不足，提供了一种用于维护健康的复方富勒烯保健饮用水。
技术方案：一种复方富勒烯保健饮用水，包括下列组份：富勒烯5ppm至200ppm；松茸提取物5ppm至500ppm。
本发明还公开了上述复方富勒烯保健饮用水的制备方法：包括下列步骤：
1)提取松茸提取物：在松茸上均匀打孔或将松茸切片，放进浓度为52％-70％的乙醇中浸泡，24至96小时，取出松茸，余下的为含有松茸溶解混合物的液体，将液体加热提纯，使得其中的乙醇通过，蒸馏分离并回收，提纯后余下的即为水溶性松茸提取物；
2)将步骤1)中所得到的松茸提取物与富勒烯按照上述比例添加到纯净去离子水中充分混合即得。
有益效果：本发明将富勒烯与松茸提取物进行混合，强力抗氧化，清除自由基，达到防癌抗癌的效果，而且步骤简单、环保；同时，经过白酒浸泡的松茸取出洗净后还可以用来食用，避免资源浪费。
具体实施方式：
实施例1：
一种复方富勒烯保健饮用水，包括下列组份：富勒烯5ppm；松茸提取物5ppm；余量为纯净去离子水。
制备方法如下：
1)提取松茸提取物：将定量的松茸上均匀打孔或切片，放进定量的浓度为52％-70％的乙醇中浸泡，24至96小时，取出松茸，余下的为含有松茸溶解混合物的液体，将液体加热提纯，使得其中的乙醇通过，蒸馏分离并回收，提纯后余下的即为水溶性松茸提取物；
2)将步骤1)中所得到的松茸提取物与富勒烯按照上述比例添加到纯净去离子水中充分混合即得。
本发明将富勒烯与松茸提取物进行混合，强力抗氧化，清除自由基，达到防癌抗癌的效果，而且步骤简单、环保；同时，经过白酒浸泡的松茸取出洗净后还可以用来食用，避免资源浪费。
实施例2：
一种复方富勒烯保健饮用水，包括下列组份：富勒烯200ppm；松茸提取物500ppm，余量为纯净去离子水。
制备方法如下：
1)提取松茸提取物：将松茸上均匀打孔或切片，放进定量的浓度为52％-70％的乙醇中浸泡，24至96小时，取出松茸，余下的为含有松茸溶解混合物的液体，将液体加热提纯，使得其中的乙醇通过，蒸馏分离并回收，提纯后余下的即为水溶性松茸提取物；
2)将步骤1)中所得到的松茸提取物与富勒烯按照上述比例添加到纯净去离子水中充分混合即得。
本发明将富勒烯与松茸提取物进行混合，强力抗氧化，清除自由基，达到防癌抗癌的效果，而且步骤简单、环保；同时，经过白酒浸泡的松茸取出洗净后还可以用来食用，避免资源浪费。
实施例3：
一种复方富勒烯保健饮用水，包括下列组份：富勒烯100ppm，松茸提取物100ppm，余量为纯净去离子水。
制备方法如下：
1)提取松茸提取物：将松茸上均匀打孔或切片，放进定量的浓度为52％-70％的乙醇中浸泡，24至96小时，取出松茸，余下的为含有松茸溶解混合物的液体，将液体加热提纯，使得其中的乙醇通过，蒸馏分离并回收，提纯后余下的即为水溶性松茸提取物；
2)将步骤1)中所得到的松茸提取物与富勒烯按照上述比例添加到纯净去离子水中充分混合即得。
本发明将富勒烯与松茸提取物进行混合，强力抗氧化，清除自由基，达到防癌抗癌的效果，而且步骤简单、环保；同时，经过白酒浸泡的松茸取出洗净后还可以用来食用，避免资源浪费。
Claims (2)
1.一种复方富勒烯保健饮用水，其特征在于：包括下列组份：富勒烯5ppm至200ppm；松茸提取物5ppm至500ppm。
2.如权利要求1所述的复方富勒烯保健饮用水的制备方法，其特征在于：包括下列步骤：
1)提取松茸提取物：在松茸上均匀打孔或将松茸切片，放进浓度为52％-70％的乙醇中浸泡，24至96小时，取出松茸，余下的为含有松茸溶解混合物的液体，将液体加热提纯，使得其中的乙醇通过蒸馏分离并回收，提纯后余下的即为水溶性松茸提取物；
2)将步骤1)中所得到的松茸提取物与富勒烯按照上述比例添加到纯净去离子水中充分混合即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610227686.7A CN105901445A (zh) | 2016-04-13 | 2016-04-13 | 复方富勒烯保健饮用水及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610227686.7A CN105901445A (zh) | 2016-04-13 | 2016-04-13 | 复方富勒烯保健饮用水及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105901445A true CN105901445A (zh) | 2016-08-31 |
Family
ID=56746887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610227686.7A Pending CN105901445A (zh) | 2016-04-13 | 2016-04-13 | 复方富勒烯保健饮用水及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105901445A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296265A (zh) * | 2017-03-02 | 2017-10-27 | 哈尔滨成程生命与物质研究所 | 精准食品综合平衡技术 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327433A (zh) * | 1999-10-22 | 2001-12-19 | 法伊鲁特股份有限公司 | 富勒烯水的制造方法及其装置 |
-
2016
- 2016-04-13 CN CN201610227686.7A patent/CN105901445A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1327433A (zh) * | 1999-10-22 | 2001-12-19 | 法伊鲁特股份有限公司 | 富勒烯水的制造方法及其装置 |
Non-Patent Citations (1)
| Title |
|---|
| 黄年来等: "《中国食药用菌学》", 31 October 2010, 上海科学技术文献出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107296265A (zh) * | 2017-03-02 | 2017-10-27 | 哈尔滨成程生命与物质研究所 | 精准食品综合平衡技术 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Healthy function and high valued utilization of edible fungi | |
| Kiew et al. | Jewel of the seabed: sea cucumbers as nutritional and drug candidates | |
| CN102153668B (zh) | 一种抗癌的黄绿蜜环菌多糖及提取工艺 | |
| Mingyu et al. | The medicinal research and development of seabuckthorn | |
| CN105796608A (zh) | 复方富勒烯保健饮用水及其制备方法 | |
| CN101716256B (zh) | 一种用于增强免疫的制剂 | |
| CN104905237A (zh) | 桦褐孔菌复合冲剂及其生产方法 | |
| CN103564495B (zh) | 一种蜂胶和虫草菌丝粉组合物及制备和应用 | |
| CN101808654B (zh) | 提取自棕榈油榨油废液的用于癌症治疗的化合物、其混合物及方法 | |
| CN105901445A (zh) | 复方富勒烯保健饮用水及其制备方法 | |
| CN104940241B (zh) | 一种防治妇女更年期综合征的硒虫草复方制剂 | |
| CN107198170A (zh) | 一种天然树莓复合口服液的制备配方 | |
| CN103919934B (zh) | 预防与治疗癌症复方制剂及其制备方法 | |
| CN107586286A (zh) | 一种从黑枸杞中提取花青素的方法 | |
| CN105477100A (zh) | 一种灵芝孢子油复方保健喷雾剂及制备方法 | |
| CN105412129A (zh) | 一种大蒜素复合液体组合物及其应用 | |
| CN103690573A (zh) | 一种用于增强免疫力的天然药物组合物及其制备方法 | |
| CN104004110A (zh) | 一种从瓜子金中提取的瓜子金多糖及其应用 | |
| CN103041369B (zh) | 藻蓝蛋白在制备防治有机磷农药所致雄性生殖毒性的药物中的应用 | |
| WO2003082308A1 (fr) | Medicaments comprenant des agents anticancereux et des immunostimulants, aliments sante et boissons associes | |
| CN102613576A (zh) | 乳房健康美丽营养片 | |
| TW201808316A (zh) | 牛樟段木栽培牛樟芝子實體及固態培養菌絲體水及乙醇萃取物之組合物應用於抗癌藥輔助劑 | |
| KR100521459B1 (ko) | 상황버섯의 유효성분이 함유된 간장의 제조방법 및 그 간장 | |
| CN101869329B (zh) | 延年益寿防癌保健饮料 | |
| CN109329897A (zh) | 一种用于癌症的辅助治疗食品组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160831 |